首页 › 基金 › Stonepine Capital Management, LLC › XENE
Stonepine Capital Management, LLC 对 XENE 的持仓历史
XENON PHARMACEUTICALS INC · 医疗保健
Stonepine Capital Management, LLC 在 Q3 2026 的 13F 申报中披露持有 XENE(XENON PHARMACEUTICALS INC)20,000 股,市值约 US$744K,约占其申报组合的 0.57%,在其申报持仓中市值排名第 35 位。 Stonepine Capital Management, LLC 于 Q3 2026 首次申报该持仓。
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
Stonepine Capital Management, LLC 对 XENE 的持仓演变
Stonepine Capital Management, LLC 于 Q3 2026 首次披露 XENE 持仓:20,000 股(约 US$744K)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2026 | 20.00K | $743.80K | 新进 |
关于 XENE 与 13F 数据
XENE(XENON PHARMACEUTICALS INC)属于医疗保健行业。我们追踪的基金中还有 34 只申报持有 XENE,申报仓位最大的包括:Avoro Capital Advisors LLC (US$348.7M), Polar Capital Holdings Plc (US$275.9M), DRIEHAUS CAPITAL MANAGEMENT LLC (US$266.7M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 XENE 的基金
- Avoro Capital Advisors LLC 5.78M 股 · $348.75M · Q2 2026
- Polar Capital Holdings Plc 4.57M 股 · $275.88M · Q2 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 4.42M 股 · $266.70M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 1.62M 股 · $97.52M · Q2 2026
- Affinity Asset Advisors, LLC 1.90M 股 · $70.67M · Q3 2026
- BRAIDWELL LP 1.13M 股 · $68.29M · Q2 2026
- ORBIMED ADVISORS LLC 892.47K 股 · $53.87M · Q2 2026
- Caligan Partners LP 889.94K 股 · $53.72M · Q2 2026
- Caption Management, LLC 728.00K 股 · $43.94M · Q2 2026
- Vestal Point Capital, LP 700.00K 股 · $42.25M · Q2 2026
- Rock Springs Capital Management LP 683.91K 股 · $41.28M · Q2 2026
更多关于 Stonepine Capital Management, LLC
常见问题
How long has Stonepine Capital Management, LLC held XENE?
Stonepine Capital Management, LLC has disclosed XENE holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Stonepine Capital Management, LLC's current position in XENE?
As of Q3 2026, Stonepine Capital Management, LLC holds 20.00K shares of XENE (XENON PHARMACEUTICALS INC), valued at $743.80K, representing 0.57% of its reported portfolio and ranking #35.
Has Stonepine Capital Management, LLC been buying or selling XENE?
In the latest 13F filing (Q3 2026), Stonepine Capital Management, LLC newly opened its position in XENE.
Which other funds hold XENE?
Other major institutional holders of XENE include Avoro Capital Advisors LLC, Polar Capital Holdings Plc, DRIEHAUS CAPITAL MANAGEMENT LLC, among 34 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.